Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating Activities
Net income	$ 1,537,000,000	$ 1,611,000,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Net realized capital gains	(332,000,000)	(7,000,000)
Amortization of deferred policy acquisition costs	1,184,000,000	1,092,000,000
Additions to deferred policy acquisition costs	(1,222,000,000)	(1,057,000,000)
Depreciation and amortization	333,000,000	359,000,000
Loss on extinguishment of debt	(90,000,000)	(6,000,000)
Gain on sale	0	(202,000,000)
Other operating activities, net	75,000,000	346,000,000
Change in assets and liabilities:
Decrease in reinsurance recoverables	115,000,000	111,000,000
Decrease (increase) in accrued and deferred income taxes	784,000,000	(74,000,000)
Increase (decrease) in insurance liabilities	630,000,000	(119,000,000)
Net change in other assets and other liabilities	(748,000,000)	(224,000,000)
Net cash provided by operating activities	2,446,000,000	1,842,000,000
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale	14,335,000,000	20,069,000,000
Fixed maturities, fair value option	7,000,000	21,000,000
Equity securities, at fair value	1,260,000,000	1,171,000,000
Mortgage loans	491,000,000	314,000,000
Partnerships	201,000,000	377,000,000
Payments for the purchase of:
Fixed maturities, available-for-sale	(15,592,000,000)	(18,679,000,000)
Equity securities, at fair value	(847,000,000)	(1,084,000,000)
Mortgage loans	(515,000,000)	(667,000,000)
Partnerships	(218,000,000)	(408,000,000)
Net proceeds from (payments for) derivatives	60,000,000	(228,000,000)
Net additions of property and equipment	(75,000,000)	(70,000,000)
Net proceeds from (payments for) short-term investments	1,480,000,000	(2,689,000,000)
Other investing activities, net	(6,000,000)	(4,000,000)
Proceeds from business sold, net of cash transferred	0	1,115,000,000
Amount paid for business acquired, net of cash acquired	(1,901,000,000)	0
Net cash used for investing activities	(1,320,000,000)	(762,000,000)
Financing Activities
Deposits and other additions to investment and universal life-type contracts	107,000,000	1,814,000,000
Withdrawals and other deductions from investment and universal life-type contracts	(101,000,000)	(9,210,000,000)
Net transfers from separate accounts related to investment and universal life-type contracts	0	6,949,000,000
Repayments at maturity or settlement of consumer notes	0	(2,000,000)
Net decrease in securities loaned or sold under agreements to repurchase	(291,000,000)	(646,000,000)
Repayment of debt	(1,583,000,000)	(826,000,000)
Proceeds from the issuance of debt	1,376,000,000	490,000,000
Net issuance (return) of shares under incentive and stock compensation plans	(18,000,000)	10,000,000
Treasury stock acquired	(90,000,000)	0
Dividends paid on preferred stock	(16,000,000)	0
Dividends paid on common stock	(327,000,000)	(270,000,000)
Net cash used for financing activities	(943,000,000)	(1,691,000,000)
Foreign exchange rate effect on cash	(14,000,000)	(4,000,000)
Net increase (decrease) in cash, including cash classified as assets held for sale	169,000,000	(615,000,000)
Less: Net increase (decrease) in cash classified as assets held for sale	0	(537,000,000)
Net increase (decrease) in cash and restricted cash	169,000,000	(78,000,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	290,000,000	102,000,000
Supplemental Disclosure of Cash Flow Information
Income tax received (paid)	420,000,000	(1,000,000)
Interest paid	$ 210,000,000	$ 197,000,000